1/16
05:41 am
amph
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]
1/15
04:03 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]
1/12
05:53 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]
1/12
06:17 am
amph
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound [Yahoo! Finance]
Medium
Report
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound [Yahoo! Finance]
12/23
10:32 am
amph
Amphastar Director Sells 16,679 Shares for $441,800 [Yahoo! Finance]
Low
Report
Amphastar Director Sells 16,679 Shares for $441,800 [Yahoo! Finance]
12/16
11:30 am
amph
Will FDA Approval of an In-House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? [Yahoo! Finance]
Low
Report
Will FDA Approval of an In-House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? [Yahoo! Finance]
12/16
07:37 am
amph
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile [Seeking Alpha]
Low
Report
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile [Seeking Alpha]
12/12
07:05 pm
amph
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges [Yahoo! Finance]
Medium
Report
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges [Yahoo! Finance]
12/10
07:17 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Barclays PLC to a "hold" rating.
12/9
09:06 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.
12/3
03:43 pm
amph
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why [Yahoo! Finance]
Neutral
Report
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why [Yahoo! Finance]
11/29
10:57 am
amph
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? [Yahoo! Finance]
11/28
09:35 pm
amph
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress [Yahoo! Finance]
Low
Report
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress [Yahoo! Finance]
11/18
07:20 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/14
10:48 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Is Up 8.4% After Strong Q3 Revenue and Key FDA Approvals [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Is Up 8.4% After Strong Q3 Revenue and Key FDA Approvals [Yahoo! Finance]